Science Explorer Interactive view Map
Company · Mainz · Germany

Novo Nordisk (Germany)

novonordisk.deROR OpenAlex
World rank, all time
#36,442
of 42,892
Rank in Germany
#1,731
of 2,077
Research works
122
▼ 25% vs 2013–17
Citations
2.2k
17.7 per fractional work
Top-10% rate
27.0%
record average 16.5%
Open access
36%
world 28%

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.69× its world share, 1 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 4.29× its world share, 7 worksBiochemistry, Geneti…Immunology and Microbiology: 0.35× its world share, 0 worksImmunology and Micro…Neuroscience: 1.94× its world share, 1 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 4.53× its world share, 0 worksPharmacology, Toxico…Chemical Engineering: 1.11× its world share, 0 worksChemical EngineeringChemistry: 0.72× its world share, 0 worksChemistryComputer Science: 0.09× its world share, 0 worksComputer ScienceEnergy: 1.34× its world share, 0 worksEnergyEngineering: 0.43× its world share, 2 worksEngineeringEnvironmental Science: 1.25× its world share, 2 worksEnvironmental ScienceMaterials Science: 0.25× its world share, 0 worksMaterials ScienceHealth Professions: 2.85× its world share, 2 worksHealth ProfessionsMedicine: 1.90× its world share, 10 worksMedicineNursing: 3.51× its world share, 0 worksNursingBusiness, Management and Accounting: 0.12× its world share, 0 worksBusiness, Management…Economics, Econometrics and Finance: 1.63× its world share, 1 worksEconomics, Econometr…Psychology: 0.13× its world share, 0 worksPsychologySocial Sciences: 0.14× its world share, 0 worksSocial Sciences1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 4.5×. Every wedge is a field page.

Who are the top researchers at Novo Nordisk (Germany)?

Ranked on the composite score, Lisa Seitz lead among researchers whose main affiliation is Novo Nordisk (Germany).

  1. 1 Lisa Seitz Germany · #1,609,957 worldwide 0 citations · 21 works
All ranked researchers at Novo Nordisk (Germany)

Which keywords describe research at Novo Nordisk (Germany)?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Glycemic Control, Cardiovascular Disease, Insulin Therapy, Obesity, Type 2 Diabetes, Public Health, Metabolic Syndrome and Clinical Guidelines.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 26 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 26 words, with their numbers
  1. Cardiovascular Disease3▲ 8.7×12 topics
  2. Glycemic Control3▲ 64×4 topics
  3. Insulin Therapy3▲ 80×3 topics
  4. Obesity3▲ 12×10 topics
  5. Public Health2▲ 5.9×9 topics
  6. Type 2 Diabetes2▲ 37×3 topics
  7. Metabolic Syndrome2▲ 9.2×7 topics
  8. Clinical Guidelines2▲ 22×2 topics
  9. Cardiovascular Outcomes2▲ 112×1 topic
  10. Diabetes2▲ 12×4 topics
  11. Glucose Control2▲ 112×1 topic
  12. Inflammation2▲ 2.9×13 topics
  13. Weight Loss2▲ 34×4 topics
  14. Chronic Diseases2▲ 21×4 topics
  15. Type 1 Diabetes2▲ 63×2 topics
  16. Epidemiology1▲ 1.25×7 topics
  17. Insulin Resistance1▲ 9.6×5 topics
  18. Healthcare Utilization1▲ 51×2 topics
  19. Metabolic Engineering1▲ 42×3 topics
  20. Oxidative Stress1▲ 2.3×8 topics
  21. Synthetic Biology1▲ 66×2 topics
  22. Constraint-Based Models1▲ 85×1 topic
  23. Genome-Scale Models1▲ 85×1 topic
  24. Germany1▲ 174×1 topic
  25. Health Surveys1▲ 174×1 topic
  26. Quality of Life1▲ 2.4×3 topics

Which research topics does Novo Nordisk (Germany) publish most on?

By volume in 2022–2025: Diabetes Treatment and Management, Diabetes Management and Research, Health and Medical Studies and Microbial Metabolic Engineering and Bioproduction.

Diabetes Treatment and M…2Diabetes Treatment and Management: 2 fractional worksDiabetes Management and Research: 1 fractional worksHealth and Medical Studies1Health and Medical Studies: 1 fractional worksMicrobial Metabolic Engi…1Microbial Metabolic Engineering and Bioproduction: 1 fractional worksHealth Systems, Economic Evaluations, Quality of Life: 1 fractional worksPharmacology and Obesity Treatment: 1 fractional worksRegulation of Appetite a…1Regulation of Appetite and Obesity: 1 fractional worksClimate Change Communication and Perception: 0 fractional worksDiet and metabolism studies: 0 fractional worksDiabetes and associated disorders: 0 fractional works
Endocrinology, Diabetes and MetabolismGeneral Health ProfessionsMolecular BiologyEconomics and Econometrics5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Diabetes Treatment and Management Endocrinology, Diabetes and Metabolism 2 works
  2. 2 Diabetes Management and Research Endocrinology, Diabetes and Metabolism 1 works
  3. 3 Health and Medical Studies General Health Professions 1 works
  4. 4 Microbial Metabolic Engineering and Bioproduction Molecular Biology 1 works
  5. 5 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 1 works
  6. 6 Pharmacology and Obesity Treatment Pharmacology 1 works
  7. 7 Regulation of Appetite and Obesity Endocrine and Autonomic Systems 1 works
  8. 8 Climate Change Communication and Perception Sociology and Political Science 0 works
  9. 9 Diet and metabolism studies Physiology 0 works
  10. 10 Diabetes and associated disorders Genetics 0 works

How open and international is its research?

Against the world’s own shares — the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available35.7%not open64.3%

World: 28% of research is openly available.

with international co-authors56.0%domestic only44.0%

World: 19% is written across borders.

How has Novo Nordisk (Germany)'s research output changed?

Output in 2018–2022 was 25% lower than in 2013–2017.

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more. The line above answers how much; this answers when.

Other research institutions in Mainz

All research institutions in Mainz

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners are in the interactive view on the map.